Inatomi Tsutomu

Okada Yo, Mori Kazuhiko, Yoshii Kengo, Inatomi Tsutomu, Kinoshita Shigeru

PreserFlo alone was safe for corneal endothelium across glaucoma types, but combining it with cataract surgery increased endothelial cell loss, especially in pseudoexfoliation glaucoma, impacting surgical planning.

Watanabe Mako, Kitazawa Koji, Fukuoka Hideki, Wakimasu Koichi, Inatomi Tsutomu, Yoshii Kengo et al.

This study found male gender, prior anterior uveitis, and glaucoma history significantly increase cytomegalovirus corneal endotheliitis risk after transplant. Close follow-up is crucial, especially in the first year.

Tomita Ryo, Asaoka Ryo, Hirasawa Kazunori, Fujino Yuri, Omura Tetsuro, Inatomi Tsutomu et al.

A study accurately predicted central 10° glaucomatous visual field loss after cataract removal using a machine learning model (RFM) with visual acuity and visual field data, but adding OCT data didn't improve accuracy.

Koizumi Noriko, Inatomi Tsutomu, Suzuki Takashi, Shiraishi Atsushi, Ohashi Yuichi, Kandori Michiko et al.

This study of CMV corneal endotheliitis in Japan found it common in older men, presenting with coin-shaped lesions, anterior uveitis, and ocular hypertension, highlighting the need for CMV suspicion in such cases.

Koizumi Noriko, Suzuki Takashi, Uno Toshihiko, Chihara Hidemi, Shiraishi Atsushi, Hara Yuko et al.

This study found cytomegalovirus (CMV) causes corneal endotheliitis, often with specific signs, responding well to early antiviral treatment. Clinicians should consider CMV in endotheliitis, even without systemic immunodeficiency.

Koizumi Noriko, Yamasaki Kenta, Kawasaki Satoshi, Sotozono Chie, Inatomi Tsutomu, Mochida Chikako et al.

This case found cytomegalovirus (CMV) DNA in aqueous humor from a non-immunodeficient patient with corneal endotheliitis, suggesting CMV can cause this condition in healthy individuals.